Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Neoplasms

abstract

  • The administration of cisplatin and irinotecan on this weekly schedule provides a practical and well-tolerated regimen that has the potential to maximize any clinical synergy between the two agents. Evidence of substantial clinical activity was seen in this phase I study.

publication date

  • December 1998

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 9850031

Additional Document Info

start page

  • 3858

end page

  • 65

volume

  • 16

number

  • 12